Gary M. Ansel

8.9k total citations · 5 hit papers
109 papers, 5.6k citations indexed

About

Gary M. Ansel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Gary M. Ansel has authored 109 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Pulmonary and Respiratory Medicine, 70 papers in Surgery and 29 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Gary M. Ansel's work include Peripheral Artery Disease Management (63 papers), Vascular Procedures and Complications (47 papers) and Cerebrovascular and Carotid Artery Diseases (34 papers). Gary M. Ansel is often cited by papers focused on Peripheral Artery Disease Management (63 papers), Vascular Procedures and Complications (47 papers) and Cerebrovascular and Carotid Artery Diseases (34 papers). Gary M. Ansel collaborates with scholars based in United States, Germany and Austria. Gary M. Ansel's co-authors include Michael R. Jaff, Thomas Zeller, Michael D. Dake, Barry T. Katzen, Richard R. Saxon, John R. Laird, H. Bob Smouse, Takao Ohki, S.A. Snyder and Dierk Scheinert and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Gary M. Ansel

103 papers receiving 5.4k citations

Hit Papers

Long-Term Results of Carotid Stenting versus Endarterecto... 2008 2026 2014 2020 2008 2010 2011 2016 2016 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients
    2008 533 citations Gary M. Ansel et al. profile →
  2. Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery
    2010 465 citations John R. Laird, Gary M. Ansel et al. Circulation Cardiovascular Interventions profile →
  3. Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease
    2011 402 citations Michael D. Dake, Gary M. Ansel et al. Circulation Cardiovascular Interventions profile →
  4. Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis
    2016 366 citations Kenneth Rosenfield, Gary M. Ansel et al. profile →
  5. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery
    2016 346 citations Michael D. Dake, Gary M. Ansel et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary M. Ansel United States 35 4.7k 3.8k 1.6k 1.0k 785 109 5.6k
James F. McKinsey United States 39 4.1k 0.9× 3.3k 0.9× 2.1k 1.3× 643 0.6× 442 0.6× 123 5.6k
Takao Ohki Japan 46 6.7k 1.4× 3.6k 0.9× 2.7k 1.7× 796 0.8× 727 0.9× 286 7.7k
Schila Sabeti Austria 32 2.9k 0.6× 2.6k 0.7× 939 0.6× 653 0.6× 280 0.4× 69 4.1k
Jerry Goldstone United States 34 3.5k 0.7× 2.3k 0.6× 1.2k 0.8× 1.1k 1.1× 834 1.1× 88 4.4k
Fred N. Littooy United States 33 2.9k 0.6× 2.1k 0.6× 2.2k 1.4× 357 0.4× 401 0.5× 89 4.3k
Patrick A. Stone United States 34 2.4k 0.5× 1.5k 0.4× 1.1k 0.7× 522 0.5× 465 0.6× 130 3.2k
J. Michael Bacharach United States 26 3.3k 0.7× 1.1k 0.3× 1.7k 1.1× 1.2k 1.2× 943 1.2× 67 3.8k
William J. Quiñones‐Baldrich United States 33 2.4k 0.5× 2.0k 0.5× 1.1k 0.7× 501 0.5× 281 0.4× 127 3.6k
P.A. Gaines United Kingdom 32 3.3k 0.7× 992 0.3× 2.0k 1.3× 1.5k 1.5× 1.4k 1.8× 105 4.1k
William C. Mackey United States 30 1.7k 0.4× 1.3k 0.3× 1.1k 0.7× 529 0.5× 610 0.8× 91 2.9k

Countries citing papers authored by Gary M. Ansel

Since Specialization
Citations

This map shows the geographic impact of Gary M. Ansel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary M. Ansel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary M. Ansel more than expected).

Fields of papers citing papers by Gary M. Ansel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary M. Ansel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary M. Ansel. The network helps show where Gary M. Ansel may publish in the future.

Co-authorship network of co-authors of Gary M. Ansel

This figure shows the co-authorship network connecting the top 25 collaborators of Gary M. Ansel. A scholar is included among the top collaborators of Gary M. Ansel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary M. Ansel. Gary M. Ansel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drachman, Douglas E., D. Christopher Metzger, Ravish Sachar, et al.. (2024). De Novo Atherosclerotic Renal Artery Stenosis Covered Stent Treatment for Resistant Hypertension (ARTISAN) Results. Journal of the Society for Cardiovascular Angiography & Interventions. 3(12). 102400–102400.
2.
3.
4.
Weissler, E. Hope, Jennifer A. Rymer, Ehrin J. Armstrong, et al.. (2020). Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease. Vascular and Endovascular Surgery. 55(2). 124–134. 8 indexed citations
5.
Weissler, E. Hope, Jennifer A. Rymer, Ehrin J. Armstrong, et al.. (2020). The impact of chronic kidney disease on outcomes following peripheral vascular intervention. Clinical Cardiology. 43(11). 1308–1316. 5 indexed citations
6.
Giannopoulos, Stefanos, Jihad Mustapha, William A. Gray, et al.. (2020). Three-Year Outcomes From the LIBERTY 360 Study of Endovascular Interventions for Peripheral Artery Disease Stratified by Rutherford Category. Journal of Endovascular Therapy. 28(2). 262–274. 18 indexed citations
7.
Dake, Michael D., Gary M. Ansel, Matthew S. Johnson, Robert Mendes, & H. Bob Smouse. (2019). The Clinical Rationale for the Sentry Bioconvertible Inferior Vena Cava Filter for the Prevention of Pulmonary Embolism. PMC.
8.
Schneider, Peter A., John R. Laird, Gheorghe Doros, et al.. (2019). Mortality Not Correlated With Paclitaxel Exposure. Journal of the American College of Cardiology. 73(20). 2550–2563. 167 indexed citations
9.
Silver, Mitchell, et al.. (2018). Percutaneous Endovascular Aortic Aneurysm Repair for Abdominal Aortic Aneurysm. Current Cardiology Reports. 20(9). 79–79. 14 indexed citations
10.
Kolluri, Raghu, et al.. (2017). A novel duplex finding of superficial epigastric vein flow reversal to diagnose iliocaval occlusion. Journal of Vascular Surgery Venous and Lymphatic Disorders. 5(3). 358–362. 4 indexed citations
11.
Dake, Michael D., Gary M. Ansel, Michael R. Jaff, et al.. (2016). Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery. Circulation. 133(15). 1472–1483. 346 indexed citations breakdown →
12.
Baker, Nevin C., Gary M. Ansel, Sunil V. Rao, et al.. (2015). The choice of arterial access for percutaneous coronary intervention and its impact on outcome: An expert opinion perspective. American Heart Journal. 170(1). 13–22. 8 indexed citations
13.
Geraghty, Patrick J., Mark W. Mewissen, Michael R. Jaff, & Gary M. Ansel. (2013). Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. Journal of Vascular Surgery. 58(2). 386–395.e4. 134 indexed citations
14.
Safian, Robert D., Michael R. Jaff, John F. Bresnahan, et al.. (2010). Protected Carotid Stenting in High‐Risk Patients: Results of the SpideRX Arm of the Carotid Revascularization with ev3 Arterial Technology Evolution Trial. Journal of Interventional Cardiology. 23(5). 491–498. 6 indexed citations
15.
Ansel, Gary M., L. Nelson Hopkins, Michael R. Jaff, et al.. (2010). Safety and effectiveness of the INVATEC MO.MA® proximal cerebral protection device during carotid artery stenting: Results from the ARMOUR pivotal trial. Catheterization and Cardiovascular Interventions. 76(1). 1–8. 121 indexed citations
16.
Ansel, Gary M. & Alan B. Lumsden. (2009). Evolving Modalities for Femoropopliteal Interventions. Journal of Endovascular Therapy. 16(SupplementII). II82–II97. 46 indexed citations
17.
Watson, Daniel, et al.. (2004). The Clinical and Fiscal Impact of Endovascular Repair of Abdominal Aortic Aneurysms. The Heart Surgery Forum. 7(5). E503–E507. 2 indexed citations
18.
Ansel, Gary M., Richard Snow, Barry S. George, et al.. (2002). Comparison of resource utilization and discharge status between aortic stent grafting and open surgical aneurysm repair in a large community hospital. Journal of the American College of Cardiology. 39. 241–242. 2 indexed citations
19.
Silva, José Antônio, Stephen R. Ramee, Tyrone J. Collins, et al.. (1998). Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: Immediate results and six-month follow-up of the multicenter AngioJet® registry. Catheterization and Cardiovascular Diagnosis. 45(4). 386–393. 77 indexed citations
20.
Ansel, Gary M., et al.. (1993). Mechanisms of Ventricular Arrhythmia During Amitriptyline Toxicity. Journal of Cardiovascular Pharmacology. 22(6). 798–803. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James F. McKinsey Breakdown of academic impact, for papers by Takao Ohki Breakdown of academic impact, for papers by Schila Sabeti Breakdown of academic impact, for papers by Jerry Goldstone Breakdown of academic impact, for papers by Fred N. Littooy Breakdown of academic impact, for papers by Patrick A. Stone Breakdown of academic impact, for papers by J. Michael Bacharach Breakdown of academic impact, for papers by William J. Quiñones‐Baldrich Breakdown of academic impact, for papers by P.A. Gaines Breakdown of academic impact, for papers by William C. Mackey
Rankless by CCL
2026